Intrapleural Paclitaxel Chemotherapy in the Treatment of Breast Cancer-Related Metastatic Malignant Pleural Effusion

Title
Intrapleural Paclitaxel Chemotherapy in the Treatment of Breast Cancer-Related Metastatic Malignant Pleural Effusion
Author(s)
이수정강수환박신영[박신영]최정은[최정은]전명훈[전명훈]
Keywords
MANAGEMENT; PLEURODESIS
Issue Date
201012
Publisher
KOREAN BREAST CANCER SOC
Citation
JOURNAL OF BREAST CANCER, v.13, no.4, pp.443 - 447
Abstract
Malignant pleural effusion in breast cancer has been associated with poor prognosis. The response rate of local treatment has been very low and in some case, complications have resulted in death. We investigated the efficacy and safety of paclitaxel, as an intrapleural chemotherapeutic agent. From January 2006 to December 2009, ten breast cancer patients who had developed malignant pleural effusion were infused with intrapleural paclitaxel through a chest tube, which was clamped for 48 hours. The chest tube was maintained until drainage was reduced to less than 50-100 mL/day. The average time spent with a chest tube attached following intrapleural chemotherapy was 9.3 days. During the follow-up period, six patients had no recurrent pleural effusion and two received a second round of intrapleural chemotherapy following which no further pleural effusion recurred. There were no severe side effects except for mild toxicity. It is suggested that intrapleural paclitaxel chemotherapy may be superior to conventional local treatment and may represent an effective treatment modality with low toxicity.
URI
http://hdl.handle.net/YU.REPOSITORY/23240http://dx.doi.org/10.4048/jbc.2010.13.4.443
ISSN
1738-6756
Appears in Collections:
의과대학 > 성형외과학교실 > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE